Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wendy Cooper

Showing results (31-40 of 49) with videos related to

Pageof 5
Sort By:
Histopathology|April 8, 2015
Equivocal ALK fluorescence in-situ hybridization (FISH) cases may benefit from ancillary ALK FISH probe testingChristina Selinger, Wendy Cooper, Trina Lum, et al.
Respirology (Carlton, Vic.)|August 16, 2014
Australian Idiopathic Pulmonary Fibrosis Registry: vital lessons from a national prospective collaborative projectYuben Moodley, Nicole Goh, Ian Glaspole, et al.
BMJ Open Respiratory Research|July 20, 2019
Cryobiopsy versus open lung biopsy in the diagnosis of interstitial lung disease (COLDICE): protocol of a multicentre studyLauren K Troy, Christopher Grainge, Tamera Corte, et al.
BMC Pulmonary Medicine|January 27, 2018
Disease progression in idiopathic pulmonary fibrosis with mild physiological impairment: analysis from the Australian IPF registryHelen E Jo, Ian Glaspole, Yuben Moodley, et al.
International Journal of Molecular Sciences|December 23, 2023
<i>KRAS</i> and <i>BRAF</i> Mutation Rates and Survival Outcomes in Colorectal Cancer in an Ethnically Diverse Patient CohortPaul Habashy, Vivienne Lea, Kate Wilkinson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 2, 2009
Phase I study of intravenous vascular endothelial growth factor trap, aflibercept, in patients with advanced solid tumorsA Craig Lockhart, Mace L Rothenberg, Jakob Dupont, et al.
Respirology (Carlton, Vic.)|March 30, 2019
Eligibility for anti-fibrotic treatment in idiopathic pulmonary fibrosis depends on the predictive equation used for pulmonary function testingAndrew Burgess, Ken Goon, John D Brannan, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|October 2, 2022
Predictive Biomarkers for Immunotherapy in Lung Cancer: Perspective From the International Association for the Study of Lung Cancer Pathology CommitteeMari Mino-Kenudson, Kurt Schalper, Wendy Cooper, et al.
Asia-Pacific Journal of Clinical Oncology|March 29, 2014
National Working Group Meeting on ALK diagnostics in lung cancerWendy Cooper, Stephen Fox, Sandra O'Toole, et al.
Archives of Pathology & Laboratory Medicine|July 3, 2020
Histopathologic Assessment of Suspected Idiopathic Pulmonary Fibrosis: Where We Are and Where We Need to GoMaxwell L Smith, Lida P Hariri, Mari Mino-Kenudson, et al.
Pageof 5

Showing results (31-40 of 49) with videos related to

Sort By:
Pageof 5
Histopathology|April 8, 2015
Equivocal ALK fluorescence in-situ hybridization (FISH) cases may benefit from ancillary ALK FISH probe testingChristina Selinger, Wendy Cooper, Trina Lum, et al.
Respirology (Carlton, Vic.)|August 16, 2014
Australian Idiopathic Pulmonary Fibrosis Registry: vital lessons from a national prospective collaborative projectYuben Moodley, Nicole Goh, Ian Glaspole, et al.
BMJ Open Respiratory Research|July 20, 2019
Cryobiopsy versus open lung biopsy in the diagnosis of interstitial lung disease (COLDICE): protocol of a multicentre studyLauren K Troy, Christopher Grainge, Tamera Corte, et al.
BMC Pulmonary Medicine|January 27, 2018
Disease progression in idiopathic pulmonary fibrosis with mild physiological impairment: analysis from the Australian IPF registryHelen E Jo, Ian Glaspole, Yuben Moodley, et al.
International Journal of Molecular Sciences|December 23, 2023
<i>KRAS</i> and <i>BRAF</i> Mutation Rates and Survival Outcomes in Colorectal Cancer in an Ethnically Diverse Patient CohortPaul Habashy, Vivienne Lea, Kate Wilkinson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 2, 2009
Phase I study of intravenous vascular endothelial growth factor trap, aflibercept, in patients with advanced solid tumorsA Craig Lockhart, Mace L Rothenberg, Jakob Dupont, et al.
Respirology (Carlton, Vic.)|March 30, 2019
Eligibility for anti-fibrotic treatment in idiopathic pulmonary fibrosis depends on the predictive equation used for pulmonary function testingAndrew Burgess, Ken Goon, John D Brannan, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|October 2, 2022
Predictive Biomarkers for Immunotherapy in Lung Cancer: Perspective From the International Association for the Study of Lung Cancer Pathology CommitteeMari Mino-Kenudson, Kurt Schalper, Wendy Cooper, et al.
Asia-Pacific Journal of Clinical Oncology|March 29, 2014
National Working Group Meeting on ALK diagnostics in lung cancerWendy Cooper, Stephen Fox, Sandra O'Toole, et al.
Archives of Pathology & Laboratory Medicine|July 3, 2020
Histopathologic Assessment of Suspected Idiopathic Pulmonary Fibrosis: Where We Are and Where We Need to GoMaxwell L Smith, Lida P Hariri, Mari Mino-Kenudson, et al.
Pageof 5